Pharmaceutical Manufacturing Global Market Report 2025

Description

Pharmaceutical manufacturing is the industrial process of creating, producing, and packaging medications and medical products at scale, utilizing chemical synthesis, biological processing, and the formulation of active and inactive ingredients. This process is conducted under strict regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for both human and veterinary use within global healthcare systems.

The primary molecule types in pharmaceutical manufacturing include biologics, biosimilars, and conventional drugs. Tablets are solid, flat medications containing a specific amount of active ingredients. Other formulations include capsules, injectables, sprays, suspensions, powders, and more, which are administered via various routes such as oral, topical, parenteral, inhalation, and others. Pharmaceutical manufacturing serves a wide range of therapy areas, including cardiovascular diseases (CVDs), pain management, diabetes, cancer, respiratory diseases, and more. These products are distributed through both retail and non-retail sales channels.

The pharmaceutical manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical manufacturing market statistics, including the pharmaceutical manufacturing industry's global market size, regional shares, competitors with an pharmaceutical manufacturing market share, detailed pharmaceutical manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing industry. This pharmaceutical manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $519.78 billion in 2024 to $573.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the increasing global disease burden, rising healthcare spending, growing demand for generic drugs, patent expirations of blockbuster drugs, and the expansion of pharmaceutical production capacity.

The pharmaceutical manufacturing market size is expected to see rapid growth in the next few years. It will grow to $846.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the rise of personalized medicine, the expanding elderly population, increasing demand for biosimilars, government support for local manufacturing, and the growing prevalence of chronic diseases. Key trends in the forecast period include advancements in continuous manufacturing, the integration of artificial intelligence, the adoption of smart manufacturing technologies, innovations in biologics production, and a focus on improving research and development efficiency.

The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical manufacturing market in the coming years. Chronic diseases are long-term health conditions that typically develop gradually and persist for a year or more, often requiring ongoing medical care or impacting daily activities. The rise in chronic diseases is largely due to increasing life expectancy, sedentary lifestyles, and poor dietary habits, all contributing to a greater need for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing plays a crucial role in addressing chronic diseases by ensuring a steady supply of essential medications, fostering innovation in drug development, and meeting the rising demand for effective long-term treatments. For example, in September 2024, the National Health Service (NHS), a UK government organization, reported that 11% of adults aged 35 and older have advanced chronic kidney disease, with the prevalence and severity increasing with age. Nearly 48% of individuals aged 75 and above suffer from some form of the disease, and 36% have more severe stages. Thus, the growing prevalence of chronic diseases is driving growth in the pharmaceutical manufacturing market.

Major companies in the pharmaceutical manufacturing market are concentrating on developing advanced solutions, such as fully automated RLT manufacturing facilities, to boost production efficiency, ensure high-quality standards, and address the rising demand for targeted cancer therapies. An automated RLT manufacturing facility utilizes advanced automation technologies to optimize and streamline the production of radioligand therapies, ensuring consistent, efficient, and scalable manufacturing. For example, in January 2024, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the US Food and Drug Administration (FDA) to produce Pluvicto at a cutting-edge radioligand therapy (RLT) manufacturing facility in Indianapolis. This expansion will significantly enhance the production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This move is part of Novartis' larger strategy to meet the growing global demand for targeted cancer therapies and improve patient access worldwide.

In December 2024, Novo Holdings A/S, a Denmark-based asset management company, acquired Catalent for $16.5 billion. This acquisition allows Novo Holdings to strengthen its position in the life sciences sector by leveraging Catalent's leading expertise in drug development, manufacturing, and clinical supply management. The move aims to accelerate growth, improve patient outcomes, and create sustainable value within the pharmaceutical and biotechnology industries. Catalent Inc. is a US-based pharmaceutical company that offers pharmaceutical manufacturing services.

Major players in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, and Jubilant Pharmova Limited.

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical manufacturing market consists of revenues earned by entities by providing services such as contract manufacturing, formulation development, quality control and testing, and packaging and labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing market also includes sales of syrups, patch formulations, biologics, and antibiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
5) By Sales Channel: Retail; Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35566

1. Executive Summary

2. Pharmaceutical Manufacturing Market Characteristics

3. Pharmaceutical Manufacturing Market Trends And Strategies

4. Pharmaceutical Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Manufacturing Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmaceutical Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pharmaceutical Manufacturing Market Growth Rate Analysis
5.4. Global Pharmaceutical Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pharmaceutical Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pharmaceutical Manufacturing Total Addressable Market (TAM)

6. Pharmaceutical Manufacturing Market Segmentation

6.1. Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics And Biosimilars
Conventional Drugs
6.2. Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Other Formulations
6.3. Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Parenteral
Inhalations
Other Route Of Administrations
6.4. Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Other Diseases
6.5. Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail
Non-retail
6.6. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Cell Therapies
Gene Therapies
Hormones
Blood And Plasma Products
6.7. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analgesics
Antipyretics
Antibiotics
Antivirals
Antifungals
Antihypertensives
Antidepressants
Antidiabetics

7. Pharmaceutical Manufacturing Market Regional And Country Analysis

7.1. Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Manufacturing Market

8.1. Asia-Pacific Pharmaceutical Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Manufacturing Market

9.1. China Pharmaceutical Manufacturing Market Overview
9.2. China Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Manufacturing Market

10.1. India Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Manufacturing Market

11.1. Japan Pharmaceutical Manufacturing Market Overview
11.2. Japan Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Manufacturing Market

12.1. Australia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Manufacturing Market

13.1. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Manufacturing Market

14.1. South Korea Pharmaceutical Manufacturing Market Overview
14.2. South Korea Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Manufacturing Market

15.1. Western Europe Pharmaceutical Manufacturing Market Overview
15.2. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Manufacturing Market

16.1. UK Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Manufacturing Market

17.1. Germany Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Manufacturing Market

18.1. France Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Manufacturing Market

19.1. Italy Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Manufacturing Market

20.1. Spain Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Manufacturing Market

21.1. Eastern Europe Pharmaceutical Manufacturing Market Overview
21.2. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Manufacturing Market

22.1. Russia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Manufacturing Market

23.1. North America Pharmaceutical Manufacturing Market Overview
23.2. North America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Manufacturing Market

24.1. USA Pharmaceutical Manufacturing Market Overview
24.2. USA Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Manufacturing Market

25.1. Canada Pharmaceutical Manufacturing Market Overview
25.2. Canada Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Manufacturing Market

26.1. South America Pharmaceutical Manufacturing Market Overview
26.2. South America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Manufacturing Market

27.1. Brazil Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Manufacturing Market

28.1. Middle East Pharmaceutical Manufacturing Market Overview
28.2. Middle East Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Manufacturing Market

29.1. Africa Pharmaceutical Manufacturing Market Overview
29.2. Africa Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Manufacturing Market Competitive Landscape And Company Profiles

30.1. Pharmaceutical Manufacturing Market Competitive Landscape
30.2. Pharmaceutical Manufacturing Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Manufacturing Market Other Major And Innovative Companies

31.1. Sanofi SA
31.2. Bristol Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. AstraZeneca plc
31.5. Abbott Laboratories
31.6. Novartis AG
31.7. GlaxoSmithKline plc
31.8. Takeda Pharmaceuticals Inc.
31.9. Eli Lilly and Company
31.10. Gilead Sciences Inc.
31.11. Novo Nordisk A/S
31.12. Lonza Group AG
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Dr. Reddy's Laboratories
31.15. Cipla Limited

32. Global Pharmaceutical Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Manufacturing Market

34. Recent Developments In The Pharmaceutical Manufacturing Market

35. Pharmaceutical Manufacturing Market High Potential Countries, Segments and Strategies

35.1 Pharmaceutical Manufacturing Market In 2029 - Countries Offering Most New Opportunities
35.2 Pharmaceutical Manufacturing Market In 2029 - Segments Offering Most New Opportunities
35.3 Pharmaceutical Manufacturing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer